Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
GSK Supply Status
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| AUGMENTIN SUSP 250/62.5MG/5ML 1X100ML_UK | 823609 | OUT OF STOCK | EARLY MAY 2026 |
| BETNOVATE RD CRM 0.025% 100G UK-GSK | 485219 | OUT OF STOCK | EARLY MAY 2026 |
| EUMOVATE CRM 0.05% 100G UK-GSK | 483503 | OUT OF STOCK | LATE APRIL 2026 |
| EUMOVATE CRM 0.05% 30G UK-GSK | 143198 | OUT OF STOCK | EARLY MAY 2026 |
| IMIGRAN N.S. 10MGX2 CP GB | 2946960 | OUT OF STOCK | LATE APRIL 2026 |
| REQUIP XL TAB 8MG 2X14_GB | 3383254 | OUT OF STOCK | LATE APRIL 2026 |
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| VARIL.VIAL WHSA +DIL.PRTC AFS GB | 2762508 | OUT OF STOCK | LATE MAY 2026 |
If you have any queries about the availability of a product, please contact your wholesaler.
3rd Party Distribution
From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.
Product name |
PIP Code |
|---|---|
| AVODART Capsules 0.5mg x 30 | 2921070 |
| COMBODART Capsules 0.5mg/0.4mg x 30 | 3542560 |
Orders can be placed at this email address:
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com
